|
Characteristic
|
N (%)
|
|---|
|
Total N = 254
|
|---|
|
Age (years)
|
|
median (range)
|
57 (23–86)
|
|
Pathology
|
|
SCC
|
232 (91.34%)
|
|
Adenocarcinoma
|
15 (5.91%)
|
|
Adenosquamous carcinoma
|
7 (2.76%)
|
|
FIGO stage
|
|
IB
|
3 (1.18%)
|
|
IIA
|
5 (1.97%)
|
|
IIB
|
200 (78.74%)
|
|
IIIA
|
11 (4.33%)
|
|
IIIB
|
25 (9.84%)
|
|
IVA
|
10 (3.94%)
|
|
Extent of lymph node involvement
|
|
None
|
98 (38.58%)
|
|
Pelvic only
|
125 (49.21%)
|
|
Pelvic + para-aortic
|
31 (12.20%)
|
|
Primary tumor size (mm)
|
|
median (range)
|
47 (14–110)
|
- Abbreviations: SCC squamous cell carcinoma, FIGO International Federation of Gynecology and Obstetrics
